Most HER2-negative BCs still express HER2 on cancer cells to some extent [6], differentiated HER2-low (IHC = 1 + or 2 + and FISH not amplified), which is now targetable, from HER2-0 (IHC = 0) [7]. This evidence concerns the gene ERBB2 and cancer.